News

Medigene collaborates with RXi Pharmaceuticals to further sharpen its therapeutic T cells

SHOW RELEASE

Medigene sells US-rights for VeregenĀ® and raises financial guidance 2017

SHOW RELEASE

Medigene announces participation at upcoming investor and scientific conferences

SHOW RELEASE

Patient recruitment completed for Phase I/II DC vaccine trial in AML

SHOW RELEASE

Medigene AG reports nine months' results 2017

SHOW RELEASE

Medigene participates at six conferences in November

SHOW RELEASE

Medigene and academic partners publish a method to identify T cell receptors against viral antigens

SHOW RELEASE

PTA-News: Medigene: Medigene announces participation at four upcoming scientific and business development conferences

SHOW RELEASE

Medigene presents automated platform for TCR identification at CAR-TCR Summit

SHOW RELEASE

Medigene presents approaches for improving selection of neoantigens for use in cancer immunotherapy

SHOW RELEASE